ConductScience.org, home

Library / Trials

Patient-Reported and Functional Outcomes After Nonoperative Management of Minimally Displaced Femoral Neck Fractures

NCT07927322, Not yet recruiting, Stanford University

Trial 9

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitlePatient-Reported and Functional Outcomes After Nonoperative Management of Minimally Displaced Femoral Neck FracturesClinicalTrials.gov
NCT numberNCT07927322ClinicalTrials.gov
StatusNot yet recruitingClinicalTrials.gov
Enrollment100 participants, estimatedClinicalTrials.gov
Lead sponsorStanford UniversityClinicalTrials.gov
ConditionsFemoral Neck FracturesClinicalTrials.gov
InterventionsNon-operative management, Operative managementClinicalTrials.gov
First posted2026-11-10ClinicalTrials.gov
Last updated2026-11-12ClinicalTrials.gov

Registered outcomes 5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryChanges in Modified Harris Hip Score6 weeks, 4 months, 12 months post injury
Changes from baseline to 12 months. The modified Harris Hip Score (mHHS) is a measure of physical function scored from 0 to 100, where higher scores indicate better physical function and lower scores indicate worse physical function.
ClinicalTrials.gov
SecondaryFailure of non-operative management6 weeks, 4 months, 12 months, 24 months post injuryFailure rate of non-operative management defined as conversion to hemiarthroplasty, or total hip arthroplasty.ClinicalTrials.gov
SecondaryChanges in Oxford Hip Score6 weeks, 4 months, 12 months, 24 months post injury
Changes from baseline to 24 months. The Oxford Hip Score is a measure of physical function scored on the 0 to 48 scale. Each of the 12 items scored 0 to 4, higher scores indicating better physical function and lower scores indicate worse physical function.
ClinicalTrials.gov
SecondaryChanges in health related quality of life6 weeks, 4 months, 12 months, 24 months post injury
Changes from baseline to 24 months in EQ-5D-5L. EQ-5D-5L is a patient reported outcome measure to measure health related quality of life scored on a 5 to 25 scale where higher scores indicate worse health status and lower scores indicates better health status.
ClinicalTrials.gov
SecondaryChanges to Barthel Index6 weeks, 4 months, 12 months, 24 months post injury
Changes from baseline to 24 months. The Barthel index is a measure of a participant's level of functional independence in basic activities of daily living. It is scored on a 0-100 scale, where higher score indicating higher level of independence and lower score indicating higher level of dependence.
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)